LABORATORY NEWS
-
Roche Launches COVID-19 PCR Test To Detect The Fast Spreading XBB.1.5 Omicron Sub-Variant
Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a COVID-19 PCR test for researchers that detects and differentiates the latest variant of concern, XBB.1.5. The XBB.1.5 variant is prevalent in the United States and is quickly spreading to other countries. Being able to differentiate emerging variants and understand their similarities and mutations provides a basis for experts to make predictions about their spread and respond with appropriate treatment strategies. The test, VirSNiP SARS-CoV-2 Spike F486P, is for use on the LightCycler® 480 II and cobas® z 480.
- VieCure And Labcorp Collaboration Will Improve Clinical Workflow, Increasing Patient Access To Genomic Testing
- Singleron Launches Single Cell eQTL Analysis As Part Of Their Sequencing Service
- Thermo Fisher Scientific Partners With AstraZeneca To Develop Solid Tissue And Blood-Based Companion Diagnostic Test For Tagrisso
- Bionano Laboratories Expands Its Clinical Testing Menu With Launch Of Its First OGM-Based Laboratory Developed Test (LDT) For Hematological Malignancies
ARCHIVED NEWSLETTER
- 01.24.23 -- FDA Seeks Comment On Circumstances For Delaying, Denying, Limiting, Or Refusing An Inspection
- 01.10.23 -- ICH Issues Draft Guideline On Viral Safety Evaluation Of Biotech Products
- 12.20.22 -- How Can Nanomedicine Innovations Combat Cancer?
- 12.06.22 -- Digital Twins & The CGT Value Chain: A Universe Of Possibilities
- 11.22.22 -- Pharma 4.0 Software Methodologies In Biopharma & Medical Devices
This website uses cookies to ensure you get the best experience on our website. Learn more